| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6093999 | Gastroenterology | 2014 | 9 Pages |
Abstract
In children newly diagnosed with comparably severe CD, early monotherapy with anti-TNFα produced better overall clinical and growth outcomes at 1 year than early monotherapy with an immunomodulator. Further data will be required to best identify children most likely to benefit from early treatment with anti-TNFα therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Thomas D. Walters, Mi-Ok Kim, Lee A. Denson, Anne M. Griffiths, Marla Dubinsky, James Markowitz, Robert Baldassano, Wallace Crandall, Joel Rosh, Marian Pfefferkorn, Anthony Otley, Melvin B. Heyman, Neal LeLeiko, Susan Baker, Stephen L. Guthery,